Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Hemoglobin | 30 | 2023 | 341 | 8.580 |
Why?
|
Hematopoiesis | 30 | 2024 | 2066 | 7.240 |
Why?
|
Erythropoiesis | 28 | 2022 | 705 | 5.330 |
Why?
|
Hematopoietic Stem Cells | 25 | 2024 | 3381 | 4.070 |
Why?
|
GATA1 Transcription Factor | 15 | 2022 | 293 | 4.010 |
Why?
|
beta-Thalassemia | 17 | 2023 | 225 | 3.850 |
Why?
|
Anemia, Diamond-Blackfan | 10 | 2021 | 137 | 3.690 |
Why?
|
Hematologic Diseases | 8 | 2023 | 498 | 2.510 |
Why?
|
Repressor Proteins | 20 | 2022 | 3020 | 2.100 |
Why?
|
Hemoglobins | 10 | 2022 | 1532 | 2.070 |
Why?
|
DNA, Mitochondrial | 10 | 2024 | 814 | 1.930 |
Why?
|
beta-Globins | 10 | 2021 | 113 | 1.790 |
Why?
|
Mutation, Missense | 9 | 2022 | 2556 | 1.780 |
Why?
|
Erythroid Precursor Cells | 8 | 2019 | 218 | 1.640 |
Why?
|
Cell Lineage | 11 | 2024 | 2504 | 1.550 |
Why?
|
Anemia | 6 | 2022 | 1499 | 1.490 |
Why?
|
Gene Silencing | 9 | 2021 | 1538 | 1.460 |
Why?
|
Anemia, Sickle Cell | 11 | 2022 | 1017 | 1.450 |
Why?
|
Thrombopoietin | 3 | 2023 | 223 | 1.440 |
Why?
|
Erythrocytes | 7 | 2022 | 2452 | 1.410 |
Why?
|
Thalassemia | 3 | 2023 | 273 | 1.400 |
Why?
|
Cell Differentiation | 24 | 2023 | 11470 | 1.400 |
Why?
|
Carrier Proteins | 14 | 2019 | 5019 | 1.390 |
Why?
|
Erythropoietin | 5 | 2020 | 724 | 1.390 |
Why?
|
Single-Cell Analysis | 10 | 2024 | 2183 | 1.380 |
Why?
|
Hemoglobinopathies | 5 | 2015 | 96 | 1.380 |
Why?
|
Gene Expression Regulation, Developmental | 12 | 2021 | 3617 | 1.370 |
Why?
|
Nuclear Proteins | 15 | 2024 | 5851 | 1.340 |
Why?
|
Thrombocytopenia | 3 | 2023 | 1171 | 1.320 |
Why?
|
Mutation | 30 | 2024 | 29717 | 1.310 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 2 | 2019 | 15 | 1.220 |
Why?
|
Blood Cells | 4 | 2022 | 309 | 1.160 |
Why?
|
Mitochondria | 8 | 2023 | 3520 | 1.110 |
Why?
|
Genetic Diseases, Inborn | 3 | 2020 | 587 | 1.100 |
Why?
|
Quantitative Trait Loci | 6 | 2022 | 2015 | 1.080 |
Why?
|
Pancytopenia | 2 | 2023 | 104 | 1.060 |
Why?
|
Chromatin | 12 | 2024 | 2917 | 0.980 |
Why?
|
Alternative Splicing | 3 | 2019 | 1118 | 0.940 |
Why?
|
Genome-Wide Association Study | 19 | 2023 | 12220 | 0.930 |
Why?
|
Hematology | 2 | 2019 | 219 | 0.920 |
Why?
|
Gene Expression Regulation | 16 | 2023 | 12071 | 0.890 |
Why?
|
Genetic Predisposition to Disease | 11 | 2022 | 17400 | 0.870 |
Why?
|
Genomics | 7 | 2023 | 5692 | 0.850 |
Why?
|
Polymorphism, Single Nucleotide | 15 | 2022 | 15494 | 0.850 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2019 | 504 | 0.800 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2022 | 136 | 0.800 |
Why?
|
Globins | 6 | 2021 | 415 | 0.790 |
Why?
|
Transcription Factors | 15 | 2024 | 12164 | 0.790 |
Why?
|
Hematinics | 2 | 2015 | 281 | 0.790 |
Why?
|
Trisomy | 3 | 2022 | 266 | 0.760 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2011 | 199 | 0.750 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2023 | 3585 | 0.750 |
Why?
|
Humans | 143 | 2024 | 742088 | 0.710 |
Why?
|
Transcription, Genetic | 10 | 2024 | 7721 | 0.700 |
Why?
|
K562 Cells | 7 | 2021 | 632 | 0.700 |
Why?
|
Erythroid Cells | 6 | 2020 | 238 | 0.690 |
Why?
|
Genetic Variation | 5 | 2020 | 6540 | 0.690 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2020 | 194 | 0.690 |
Why?
|
Proto-Oncogene Proteins | 5 | 2020 | 4553 | 0.670 |
Why?
|
Ribosomes | 3 | 2020 | 499 | 0.670 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2020 | 198 | 0.670 |
Why?
|
Introns | 2 | 2019 | 991 | 0.660 |
Why?
|
Anemia, Aplastic | 1 | 2020 | 226 | 0.650 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 142 | 0.650 |
Why?
|
Fanconi Anemia | 2 | 2019 | 319 | 0.640 |
Why?
|
Isoquinolines | 1 | 2020 | 368 | 0.630 |
Why?
|
Primary Myelofibrosis | 1 | 2020 | 214 | 0.620 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 732 | 0.610 |
Why?
|
Phenotype | 20 | 2023 | 16331 | 0.590 |
Why?
|
Ribosomal Proteins | 7 | 2021 | 360 | 0.590 |
Why?
|
Disease | 1 | 2022 | 681 | 0.580 |
Why?
|
Mosaicism | 1 | 2019 | 440 | 0.580 |
Why?
|
Hemoglobin A | 2 | 2015 | 87 | 0.580 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2019 | 628 | 0.570 |
Why?
|
Glycine | 1 | 2020 | 671 | 0.560 |
Why?
|
Genetic Techniques | 2 | 2016 | 435 | 0.560 |
Why?
|
Clone Cells | 5 | 2024 | 1692 | 0.550 |
Why?
|
Base Sequence | 8 | 2022 | 12797 | 0.550 |
Why?
|
Cell Cycle | 4 | 2023 | 2964 | 0.540 |
Why?
|
Blood Transfusion, Autologous | 1 | 2016 | 134 | 0.540 |
Why?
|
Quantitative Trait, Heritable | 1 | 2019 | 544 | 0.530 |
Why?
|
HEK293 Cells | 7 | 2021 | 4200 | 0.530 |
Why?
|
Common Variable Immunodeficiency | 1 | 2016 | 93 | 0.530 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 286 | 0.530 |
Why?
|
Phosphoproteins | 2 | 2024 | 2440 | 0.530 |
Why?
|
Cyclin A2 | 1 | 2015 | 21 | 0.520 |
Why?
|
Ikaros Transcription Factor | 1 | 2016 | 214 | 0.520 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2019 | 232 | 0.510 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 55 | 0.510 |
Why?
|
Protein Biosynthesis | 4 | 2020 | 2126 | 0.510 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2015 | 57 | 0.510 |
Why?
|
Response Elements | 1 | 2016 | 311 | 0.490 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1675 | 0.490 |
Why?
|
Leukemia | 1 | 2022 | 1507 | 0.490 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 603 | 0.480 |
Why?
|
Chromosome Disorders | 2 | 2021 | 515 | 0.480 |
Why?
|
SOXD Transcription Factors | 2 | 2011 | 47 | 0.480 |
Why?
|
Neoplasms | 7 | 2023 | 21596 | 0.480 |
Why?
|
Anemia, Neonatal | 1 | 2013 | 18 | 0.470 |
Why?
|
Cytokinesis | 1 | 2015 | 177 | 0.460 |
Why?
|
Cells, Cultured | 12 | 2021 | 19223 | 0.460 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1899 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2017 | 774 | 0.450 |
Why?
|
Sequence Deletion | 2 | 2015 | 1526 | 0.450 |
Why?
|
Blood Platelets | 3 | 2019 | 2506 | 0.440 |
Why?
|
Cyclin D3 | 1 | 2012 | 55 | 0.440 |
Why?
|
gamma-Globins | 5 | 2011 | 95 | 0.440 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2013 | 76 | 0.430 |
Why?
|
Antisickling Agents | 1 | 2013 | 80 | 0.430 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4664 | 0.430 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2915 | 0.420 |
Why?
|
Heterozygote | 2 | 2016 | 2790 | 0.410 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1820 | 0.410 |
Why?
|
Genome | 2 | 2023 | 1803 | 0.400 |
Why?
|
Genetic Loci | 3 | 2016 | 2572 | 0.400 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 370 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2011 | 78 | 0.380 |
Why?
|
Bone Marrow Diseases | 2 | 2023 | 230 | 0.370 |
Why?
|
Family | 2 | 2019 | 3144 | 0.370 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2020 | 5425 | 0.360 |
Why?
|
Computational Biology | 1 | 2022 | 3518 | 0.360 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4187 | 0.360 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2015 | 615 | 0.360 |
Why?
|
alpha-Globins | 3 | 2018 | 17 | 0.360 |
Why?
|
Phloretin | 2 | 2019 | 17 | 0.350 |
Why?
|
Point Mutation | 1 | 2015 | 1624 | 0.350 |
Why?
|
Animals | 38 | 2023 | 168561 | 0.340 |
Why?
|
Zinc Fingers | 2 | 2021 | 585 | 0.340 |
Why?
|
RNA, Messenger | 5 | 2022 | 13029 | 0.340 |
Why?
|
Receptors, Erythropoietin | 3 | 2019 | 147 | 0.340 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1351 | 0.330 |
Why?
|
Transcriptional Activation | 2 | 2013 | 1782 | 0.310 |
Why?
|
Infant, Premature, Diseases | 1 | 2013 | 706 | 0.300 |
Why?
|
Retinoblastoma Protein | 2 | 2008 | 701 | 0.300 |
Why?
|
Epigenomics | 3 | 2022 | 902 | 0.290 |
Why?
|
Iron Overload | 2 | 2021 | 243 | 0.290 |
Why?
|
Pedigree | 4 | 2021 | 4646 | 0.280 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3639 | 0.260 |
Why?
|
Erythroblasts | 5 | 2019 | 150 | 0.250 |
Why?
|
Genetic Association Studies | 5 | 2021 | 2699 | 0.250 |
Why?
|
Embryonic Development | 2 | 2022 | 704 | 0.250 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1190 | 0.240 |
Why?
|
Male | 37 | 2023 | 349538 | 0.240 |
Why?
|
Leukocyte Count | 2 | 2019 | 1583 | 0.240 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2019 | 794 | 0.230 |
Why?
|
Molecular Targeted Therapy | 3 | 2013 | 2723 | 0.230 |
Why?
|
Chondroitinsulfatases | 1 | 2023 | 16 | 0.230 |
Why?
|
MicroRNAs | 4 | 2020 | 3731 | 0.230 |
Why?
|
Mice | 22 | 2023 | 81045 | 0.230 |
Why?
|
Female | 34 | 2023 | 379592 | 0.230 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2023 | 440 | 0.220 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16665 | 0.220 |
Why?
|
Child | 14 | 2023 | 77478 | 0.220 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 48 | 0.210 |
Why?
|
Signal Transduction | 7 | 2023 | 23387 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3563 | 0.210 |
Why?
|
Megakaryocytes | 3 | 2016 | 542 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Linkage Disequilibrium | 2 | 2019 | 1995 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9639 | 0.200 |
Why?
|
Cell Size | 2 | 2015 | 643 | 0.200 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 96 | 0.200 |
Why?
|
DNA, Intergenic | 1 | 2022 | 107 | 0.200 |
Why?
|
Gene Knockdown Techniques | 3 | 2016 | 1655 | 0.200 |
Why?
|
Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2021 | 11 | 0.200 |
Why?
|
Dihydroorotase | 1 | 2021 | 11 | 0.200 |
Why?
|
Aspartate Carbamoyltransferase | 1 | 2021 | 22 | 0.200 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2022 | 80 | 0.190 |
Why?
|
Lipomatosis | 1 | 2022 | 112 | 0.190 |
Why?
|
Antioxidants | 2 | 2019 | 1659 | 0.190 |
Why?
|
Chromosome Breakage | 1 | 2021 | 173 | 0.190 |
Why?
|
Epoetin Alfa | 1 | 2020 | 83 | 0.190 |
Why?
|
Genes, Switch | 2 | 2010 | 47 | 0.190 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2001 | 209 | 0.190 |
Why?
|
Uridine | 1 | 2021 | 146 | 0.190 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2020 | 62 | 0.180 |
Why?
|
Child, Preschool | 10 | 2022 | 40955 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.180 |
Why?
|
Adult | 23 | 2023 | 213712 | 0.180 |
Why?
|
Heme | 2 | 2019 | 307 | 0.180 |
Why?
|
Species Specificity | 3 | 2014 | 2479 | 0.180 |
Why?
|
Embryo, Mammalian | 3 | 2018 | 1692 | 0.180 |
Why?
|
Ankyrin Repeat | 1 | 2019 | 17 | 0.180 |
Why?
|
Mitochondrial Diseases | 1 | 2023 | 321 | 0.170 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9410 | 0.170 |
Why?
|
alpha-Thalassemia | 2 | 2018 | 46 | 0.170 |
Why?
|
Chromosome Mapping | 2 | 2019 | 4742 | 0.170 |
Why?
|
Endopeptidases | 1 | 2023 | 772 | 0.170 |
Why?
|
RNA Polymerase II | 1 | 2023 | 550 | 0.170 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2022 | 892 | 0.170 |
Why?
|
Gene Deletion | 4 | 2018 | 2751 | 0.170 |
Why?
|
Scurvy | 1 | 2019 | 29 | 0.170 |
Why?
|
Pluripotent Stem Cells | 2 | 2016 | 795 | 0.170 |
Why?
|
Siblings | 2 | 2021 | 854 | 0.170 |
Why?
|
Leukemia, Myeloid | 1 | 2022 | 705 | 0.170 |
Why?
|
Gene Regulatory Networks | 3 | 2022 | 1707 | 0.170 |
Why?
|
Transposases | 1 | 2019 | 104 | 0.170 |
Why?
|
Genome, Human | 5 | 2022 | 4420 | 0.170 |
Why?
|
Cation Transport Proteins | 1 | 2001 | 327 | 0.160 |
Why?
|
Benzoates | 1 | 2020 | 217 | 0.160 |
Why?
|
Hydrazines | 1 | 2020 | 220 | 0.160 |
Why?
|
DNA Copy Number Variations | 4 | 2022 | 1940 | 0.160 |
Why?
|
eIF-2 Kinase | 1 | 2019 | 150 | 0.160 |
Why?
|
Symporters | 1 | 2001 | 363 | 0.160 |
Why?
|
Receptors, Cytokine | 1 | 2019 | 261 | 0.160 |
Why?
|
Plasma Cells | 1 | 2022 | 592 | 0.160 |
Why?
|
Trans-Activators | 2 | 2023 | 2924 | 0.160 |
Why?
|
Chromosomes | 1 | 2021 | 595 | 0.160 |
Why?
|
Rare Diseases | 1 | 2023 | 554 | 0.160 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 343 | 0.160 |
Why?
|
HeLa Cells | 2 | 2021 | 3127 | 0.160 |
Why?
|
Chitosan | 1 | 2019 | 140 | 0.160 |
Why?
|
RNA Splice Sites | 1 | 2019 | 209 | 0.160 |
Why?
|
Developing Countries | 1 | 2010 | 2789 | 0.160 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4328 | 0.160 |
Why?
|
Protein Binding | 5 | 2019 | 9387 | 0.150 |
Why?
|
Embryonic Stem Cells | 2 | 2015 | 1294 | 0.150 |
Why?
|
Hemoglobin, Sickle | 1 | 2018 | 122 | 0.150 |
Why?
|
Phospholipids | 1 | 2001 | 781 | 0.150 |
Why?
|
Sickle Cell Trait | 1 | 2018 | 81 | 0.150 |
Why?
|
Biological Evolution | 1 | 2023 | 1074 | 0.150 |
Why?
|
Biomimetic Materials | 1 | 2019 | 179 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2016 | 12 | 0.150 |
Why?
|
Estonia | 1 | 2016 | 53 | 0.150 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5867 | 0.150 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3504 | 0.150 |
Why?
|
Genetic Engineering | 1 | 2023 | 952 | 0.150 |
Why?
|
Cell Line | 4 | 2021 | 15994 | 0.150 |
Why?
|
Models, Biological | 5 | 2022 | 9581 | 0.150 |
Why?
|
5' Untranslated Regions | 1 | 2018 | 249 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2020 | 546 | 0.140 |
Why?
|
Porphyrias | 1 | 2016 | 57 | 0.140 |
Why?
|
Genes, myb | 2 | 2013 | 18 | 0.140 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 161 | 0.140 |
Why?
|
Exons | 2 | 2019 | 2431 | 0.140 |
Why?
|
Infant, Newborn | 5 | 2023 | 25575 | 0.140 |
Why?
|
Megakaryocyte-Erythroid Progenitor Cells | 1 | 2015 | 10 | 0.130 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 211 | 0.130 |
Why?
|
Inosine | 1 | 2016 | 133 | 0.130 |
Why?
|
Cell Membrane | 2 | 2023 | 3744 | 0.130 |
Why?
|
Protein Engineering | 1 | 2019 | 541 | 0.130 |
Why?
|
Homeostasis | 2 | 2020 | 3335 | 0.130 |
Why?
|
Mice, Knockout | 7 | 2020 | 14554 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 565 | 0.130 |
Why?
|
RNA Interference | 2 | 2018 | 2890 | 0.130 |
Why?
|
Consanguinity | 1 | 2017 | 456 | 0.130 |
Why?
|
Pyridoxal Phosphate | 1 | 2015 | 127 | 0.130 |
Why?
|
RNA Editing | 1 | 2016 | 148 | 0.130 |
Why?
|
Biomedical Research | 1 | 2010 | 3306 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2638 | 0.130 |
Why?
|
Basophils | 1 | 2016 | 389 | 0.120 |
Why?
|
Blood Transfusion | 3 | 2021 | 1296 | 0.120 |
Why?
|
Genes, X-Linked | 1 | 2015 | 128 | 0.120 |
Why?
|
Cell Transplantation | 1 | 2016 | 477 | 0.120 |
Why?
|
Porphyrins | 1 | 2016 | 348 | 0.120 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 241 | 0.120 |
Why?
|
Reticulocytes | 1 | 2015 | 290 | 0.120 |
Why?
|
Genotype | 6 | 2023 | 12946 | 0.120 |
Why?
|
Peptide Elongation Factors | 1 | 2013 | 62 | 0.120 |
Why?
|
Isoantigens | 1 | 2016 | 567 | 0.120 |
Why?
|
Down Syndrome | 1 | 2022 | 880 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 527 | 0.120 |
Why?
|
Platelet Count | 1 | 2016 | 780 | 0.120 |
Why?
|
Doxycycline | 1 | 2015 | 326 | 0.110 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2020 | 2195 | 0.110 |
Why?
|
Evolution, Molecular | 2 | 2014 | 1937 | 0.110 |
Why?
|
Kinetics | 2 | 2022 | 6474 | 0.110 |
Why?
|
Gene Library | 1 | 2016 | 1076 | 0.110 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 559 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1533 | 0.110 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 183 | 0.110 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 224 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4801 | 0.110 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1875 | 0.110 |
Why?
|
Receptors, Transferrin | 2 | 2011 | 296 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6608 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1158 | 0.110 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 380 | 0.110 |
Why?
|
Fetal Blood | 2 | 2016 | 1317 | 0.110 |
Why?
|
Blotting, Western | 4 | 2016 | 5180 | 0.110 |
Why?
|
Leukocytes | 1 | 2020 | 2039 | 0.110 |
Why?
|
Infant | 5 | 2020 | 35070 | 0.110 |
Why?
|
Puerperal Disorders | 1 | 2015 | 275 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2015 | 880 | 0.100 |
Why?
|
Genes, Reporter | 1 | 2016 | 1547 | 0.100 |
Why?
|
Regenerative Medicine | 1 | 2015 | 306 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7790 | 0.100 |
Why?
|
Morbidity | 2 | 2021 | 1767 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2715 | 0.100 |
Why?
|
Binding Sites | 2 | 2020 | 6115 | 0.100 |
Why?
|
Risk | 2 | 2021 | 9679 | 0.100 |
Why?
|
Oxygen | 2 | 2020 | 4169 | 0.100 |
Why?
|
Hydroxyurea | 1 | 2013 | 290 | 0.100 |
Why?
|
Transcriptional Elongation Factors | 2 | 2023 | 166 | 0.100 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2013 | 404 | 0.100 |
Why?
|
Adenosine | 1 | 2016 | 823 | 0.100 |
Why?
|
Conserved Sequence | 1 | 2014 | 1202 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1847 | 0.100 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2123 | 0.100 |
Why?
|
Azacitidine | 1 | 2013 | 347 | 0.100 |
Why?
|
Transfection | 1 | 2019 | 5892 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2017 | 3701 | 0.090 |
Why?
|
Prenatal Care | 1 | 2018 | 1088 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1773 | 0.090 |
Why?
|
Sri Lanka | 1 | 2010 | 90 | 0.090 |
Why?
|
Professional Practice | 1 | 2013 | 326 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 18112 | 0.090 |
Why?
|
Physical Chromosome Mapping | 1 | 2010 | 183 | 0.090 |
Why?
|
Neutrophils | 1 | 2023 | 3711 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1596 | 0.090 |
Why?
|
Lymphopoiesis | 1 | 2011 | 133 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3618 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1337 | 0.090 |
Why?
|
Flow Cytometry | 5 | 2016 | 5975 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2513 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1970 | 0.090 |
Why?
|
Iron Chelating Agents | 1 | 2010 | 139 | 0.090 |
Why?
|
Proteins | 3 | 2021 | 6096 | 0.090 |
Why?
|
Codon, Nonsense | 1 | 2010 | 281 | 0.090 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3691 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 970 | 0.090 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10163 | 0.090 |
Why?
|
Histones | 3 | 2014 | 2597 | 0.080 |
Why?
|
Models, Animal | 2 | 2018 | 2170 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2589 | 0.080 |
Why?
|
Zebrafish | 2 | 2020 | 2990 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1670 | 0.080 |
Why?
|
Integrases | 2 | 2008 | 533 | 0.080 |
Why?
|
Cell Communication | 1 | 2016 | 1619 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1831 | 0.080 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2008 | 113 | 0.080 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 314 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2022 | 581 | 0.080 |
Why?
|
Cohort Studies | 7 | 2021 | 40450 | 0.080 |
Why?
|
Mammals | 2 | 2023 | 1135 | 0.080 |
Why?
|
Nanoparticles | 1 | 2019 | 1902 | 0.080 |
Why?
|
Software | 1 | 2021 | 4434 | 0.080 |
Why?
|
Adolescent | 7 | 2021 | 85649 | 0.070 |
Why?
|
Down-Regulation | 2 | 2019 | 3001 | 0.070 |
Why?
|
Bone Marrow | 2 | 2023 | 2941 | 0.070 |
Why?
|
Protein Conformation | 1 | 2015 | 4013 | 0.070 |
Why?
|
Aging | 2 | 2024 | 8626 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1989 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 2866 | 0.070 |
Why?
|
Apoptosis | 2 | 2020 | 9715 | 0.070 |
Why?
|
Models, Molecular | 2 | 2015 | 5454 | 0.070 |
Why?
|
Genes, p53 | 1 | 2008 | 755 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 2022 | 657 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1224 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1417 | 0.070 |
Why?
|
Multigene Family | 1 | 2008 | 1102 | 0.060 |
Why?
|
Pregnancy | 2 | 2018 | 29087 | 0.060 |
Why?
|
Young Adult | 8 | 2021 | 56350 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.060 |
Why?
|
Cytokines | 2 | 2019 | 7317 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7167 | 0.060 |
Why?
|
Aged | 7 | 2023 | 162944 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 729 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5169 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1727 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1835 | 0.060 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4211 | 0.060 |
Why?
|
Middle Aged | 8 | 2023 | 213127 | 0.060 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1786 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.060 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2023 | 206 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2023 | 57683 | 0.050 |
Why?
|
Receptor, EphB3 | 1 | 2022 | 11 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2008 | 880 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2422 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2011 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2019 | 7873 | 0.050 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2022 | 80 | 0.050 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2022 | 67 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9735 | 0.050 |
Why?
|
Antiporters | 1 | 2023 | 277 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1618 | 0.050 |
Why?
|
Fetus | 1 | 2009 | 1879 | 0.050 |
Why?
|
DNA Methylation | 2 | 2013 | 4282 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2022 | 365 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2022 | 227 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6534 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 6171 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2016 | 10472 | 0.050 |
Why?
|
Models, Genetic | 1 | 2011 | 3493 | 0.050 |
Why?
|
Inositol Phosphates | 1 | 2000 | 180 | 0.050 |
Why?
|
MELAS Syndrome | 1 | 2020 | 50 | 0.050 |
Why?
|
Mortality | 2 | 2021 | 2857 | 0.050 |
Why?
|
Genome, Mitochondrial | 1 | 2020 | 71 | 0.050 |
Why?
|
Bone and Bones | 1 | 2011 | 2575 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4024 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2021 | 2257 | 0.050 |
Why?
|
Calmodulin | 1 | 2020 | 209 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2020 | 142 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2001 | 1159 | 0.040 |
Why?
|
Genetics | 1 | 2020 | 112 | 0.040 |
Why?
|
GRB10 Adaptor Protein | 1 | 2019 | 22 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2022 | 340 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2000 | 291 | 0.040 |
Why?
|
Blood Proteins | 2 | 2001 | 1122 | 0.040 |
Why?
|
Glutathione Transferase | 1 | 2001 | 595 | 0.040 |
Why?
|
Inflammation | 2 | 2019 | 10578 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6754 | 0.040 |
Why?
|
Activating Transcription Factor 4 | 1 | 2019 | 81 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2021 | 222 | 0.040 |
Why?
|
Ribosome Subunits, Large | 1 | 2018 | 5 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
Cytochromes c | 1 | 2019 | 180 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2023 | 591 | 0.040 |
Why?
|
Africa | 1 | 2020 | 670 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2019 | 270 | 0.040 |
Why?
|
United States | 3 | 2020 | 69693 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2019 | 190 | 0.040 |
Why?
|
Microscopy | 1 | 2023 | 903 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39004 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2019 | 295 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6931 | 0.040 |
Why?
|
Liposomes | 1 | 2001 | 758 | 0.040 |
Why?
|
Erythrocytes, Abnormal | 1 | 2018 | 125 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15530 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2022 | 1099 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2019 | 230 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 556 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 707 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7153 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1265 | 0.040 |
Why?
|
Caspase 3 | 1 | 2019 | 759 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2019 | 419 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3248 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 730 | 0.040 |
Why?
|
Algorithms | 2 | 2022 | 13853 | 0.040 |
Why?
|
Schizophrenia | 1 | 2015 | 6874 | 0.030 |
Why?
|
Atrophy | 1 | 2021 | 1576 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 2016 | 115 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2016 | 354 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2016 | 2837 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2522 | 0.030 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 146 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2016 | 2713 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20086 | 0.030 |
Why?
|
Myelopoiesis | 1 | 2016 | 131 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13655 | 0.030 |
Why?
|
Lipoproteins | 1 | 2000 | 876 | 0.030 |
Why?
|
Cricetinae | 1 | 2019 | 2471 | 0.030 |
Why?
|
Retroelements | 1 | 2016 | 164 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2019 | 364 | 0.030 |
Why?
|
Granulocytes | 1 | 2016 | 546 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 21719 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1011 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 496 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 905 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3847 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 971 | 0.030 |
Why?
|
Mouth Neoplasms | 1 | 2019 | 601 | 0.030 |
Why?
|
Computer Simulation | 2 | 2022 | 6191 | 0.030 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 323 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 808 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 846 | 0.030 |
Why?
|
Pain | 1 | 2008 | 4961 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2023 | 2749 | 0.030 |
Why?
|
Interferons | 1 | 2016 | 704 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3770 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18006 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2021 | 1452 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1434 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3293 | 0.030 |
Why?
|
Biological Transport | 1 | 2016 | 2119 | 0.030 |
Why?
|
Prognosis | 2 | 2022 | 29010 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2003 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3571 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2014 | 766 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2450 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2000 | 2938 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8425 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3439 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3444 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2167 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2010 | 803 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2906 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2948 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 21821 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3387 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77098 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9846 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2948 | 0.020 |
Why?
|
Lentivirus | 1 | 2010 | 501 | 0.020 |
Why?
|
Mesoderm | 1 | 2011 | 686 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6382 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2011 | 575 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12344 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62966 | 0.020 |
Why?
|
Italy | 1 | 2008 | 828 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4143 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1749 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2359 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1988 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3862 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4029 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3695 | 0.010 |
Why?
|
Tumor Burden | 1 | 2008 | 1905 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 72145 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11472 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3420 | 0.010 |
Why?
|
Gene Frequency | 1 | 2008 | 3587 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23320 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5724 | 0.010 |
Why?
|
Hydrogen Bonding | 1 | 2000 | 293 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19862 | 0.010 |
Why?
|
src Homology Domains | 1 | 2000 | 364 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4839 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2000 | 1245 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1802 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2000 | 2014 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15108 | 0.010 |
Why?
|
Fatty Acids | 1 | 2000 | 1806 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 24913 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13814 | 0.000 |
Why?
|